2 ml SmartScan Racks from ABgene
Rabbit Anti-Leptin Receptor Polyclonal Antibody, Unconjugated from BioVision
...a compact, highly versatile power supply. Capable ...is power supply is ideal for PAGE, SDS-PAGE, DNA o... format transfer apparatus. It is designed to oper... continuously variable output in either mode. The ...
...body This antibody is generated from rabbits immun...ted within aa 50~150 of human PLAU. Purified rabbi...W/V) sodium azide. This antibody is purified throu...h and low pH buffers and neutralized immediately a...
Biology Products:(Date:11/26/2009)...out in eight European countries has shown that clo... pandemic could have a significant role in reducin... open access journal BMC Infectious Diseases com...nd weekends/holidays, finding that they were reduc...elt and Antwerp University, Belgium, led a team of...
(Date:11/26/2009)...7 November 2009 What are the bare essentials of l...duce a cell that can survive on its own? Can we de...tand how an entire organism functions as a system?...sts in a partnership between the European Molecula..., and the Centre de Regulacio Genmica (CRG) in Bar...
(Date:11/25/2009)...cientists at the California Institute of Technolog... emotion-like behavior in the fruit fly, Drosophi... relevant to the relationship between the neurotra...ity disorder (ADHD), are described in the December...a brain contains only about 20,000 neurons and ha...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Study 3A Smoking may worsen malnutrition in developing nations 9674 1Study 3A Smoking may worsen malnutrition in developing nations 9674 2Medical Advances Population Changes Fuel Demand for Rehabilitation Professionals 55084 1Medical Advances Population Changes Fuel Demand for Rehabilitation Professionals 55084 2Fragile period of childhood brain development could underlie epilepsy 55082 1Fragile period of childhood brain development could underlie epilepsy 55082 2(Date:11/24/2009)...care employment grew by 29,000 jobs in October, a...nt growth during the U.S. recession. However, clin... health systems are coming closer to having to act...istrators. , (Vocus) Nove...growing in October despite the shedding of jobs in...
(Date:11/24/2009)... Nov. 24 NeurogesX, Inc....used on developing and commercializing novel pain ... DiTonno, President and Chief Executive Officer, i...ffray Health Care Conference, to be held December ..., New York. ,, Mr. DiTonno and Stephen Ghiglie...
(Date:11/24/2009)...recently approved the Promega PowerPlex 16 HS Syst...erating DNA records for the National DNA Index Sys...RWEB) -- The FBI recently approved the Promega Po... participating in, or generating DNA records for, ...ly contains more than seven million profiles and h...
(Date:11/24/2009)...24 Shire plc (LSE: SHP,...utical company, today,announced that it has submit...aglucerase alfa, the company,s enzyme replacement ... Gaucher disease. This is the third marketing,appl...tted, with previous,submissions in the United Stat...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4